CPhI China 2026 will take place from 16–18 June 2026 at the Shanghai New International Expo Centre (SNIEC) in Shanghai. This event represents Asia’s premier pharmaceutical industry gathering and spans the full pharma value chain.

Event Scope & Purpose

CPhI China gives companies a single platform to source ingredients, find partners, and showcase innovations.
It connects global and Chinese pharmaceutical professionals.
Attendees can explore APIs, excipients, finished dosages, biopharma, natural extracts, and contract services — all under one roof.

Main Topics & Focus Areas

The show highlights active pharmaceutical ingredients (APIs), intermediates, and fine chemicals.
It also features excipients, formulations, and finished dosage forms.
Biopharmaceuticals, natural extracts, and contract manufacturing/outsourcing services have strong representation.
Further focus includes pharmaceutical machinery, production technologies, packaging, drug‑delivery systems, lab & cleanroom equipment, and environmental/processing solutions.

Who Attends & Key Visitors

CPhI China draws pharmaceutical manufacturers, API and raw‑material suppliers, biopharma developers, and contract manufacturing organizations (CMOs/CROs).
R&D teams, procurement and supply‑chain managers, regulatory experts, and quality assurance professionals also attend.
Additionally, machinery and equipment vendors, packaging specialists, and service providers for drug delivery and lab technologies join the event.

Outstanding Opportunities

CPhI China offers unmatched access to China’s vast and growing pharmaceutical market.
Exhibitors can meet thousands of potential partners and negotiate supply, outsourcing or contract manufacturing deals.
The event also enables newcomers and established firms alike to benchmark technologies, launch new products, and align with evolving regulatory and industry standards.

Industries Represented

CPhI China spans the chemical‑pharmaceutical industry, biopharma, fine chemicals, natural‑extracts supply, contract manufacturing, and pharma outsourcing services.
It also includes sectors connected to equipment, production technology, packaging & drug delivery, laboratory instruments, clean‑room systems, and quality control.